LAUREN WEIDMAN: Open Payments
NPI 1760039663 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,260 in 283 payments from 21 companies in 2025. Trend: 2023 $2,596 · 2024 $3,323 · 2025 $5,260
Food & beverage: $5,217Education: $43
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 22 | $590 |
| LEO Pharma Inc. | 31 | $560 |
| ABBVIE INC. | 30 | $462 |
| Organon LLC | 27 | $418 |
| Amgen Inc. | 12 | $326 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 18 | $324 |
| Janssen Biotech, Inc. | 18 | $317 |
| Arcutis Biotherapeutics, Inc. | 15 | $302 |
| GENZYME CORPORATION | 16 | $295 |
| Novartis Pharmaceuticals Corporation | 22 | $284 |
Products named: Bimzelx, DUPIXENT, SKYRIZI, Otezla, VTAMA, TREMFYA, ADBRY, OPZELURA.
Industry payments across AZ — which companies pay providers there.
